End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7,81,000 KRW | +0.77% | -2.62% | +2.76% |
25/04 | Samsung Bioepis Granted Approval to Market Autoimmune Treatment in Europe | MT |
25/04 | Samsung Biologics Posts Higher Q1 Profit, Sales | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.76% | 40.16B | |
-4.24% | 86.85B | |
-16.98% | 31.28B | |
+57.86% | 25.27B | |
-16.24% | 15.33B | |
-9.12% | 11.96B | |
-42.56% | 11.61B | |
-17.10% | 11.69B | |
+6.89% | 8.83B | |
-10.53% | 7.94B |
- Stock Market
- Equities
- A207940 Stock
- News Samsung Biologics Co.,Ltd.
- Market Chatter: Samsung Biologics Eyes Inaugural Public Bond Offering